Market Cap ₹3487 Cr.
Stock P/E 92.7
P/B 10.8
Current Price ₹585
Book Value ₹ 54.3
Face Value 2
52W High ₹1407.2
Dividend Yield 0.07%
52W Low ₹ 237.4
Manorama Industries Ltd manufactures, processes, and substances speciality fats and butters from tree-borne, and plant-based seeds and nuts in India and internationally. The corporation offers shea butter and fats, sal butter, sal fat, sal oil, sal stearine, sal olein, mango butter and fats, mango oil, mango stearine, kokum butter and oil, mowrah fats, and de-oiled cakes, in addition to dhupa, mowrah, and phulwara butter. It also presents sal, kokum, rice bran, shea, and mango kernel meal; and organic castor, neem, karanja, safflower, moringa, and rice bran oil. In addition, the organization trades in cassia tora seed, rice, wheat, sugar, maize, raw cotton, cotton linter, maize/corn, soy meal, cotton seed meal, rice bran meal, sesame, sorghum yellow and white, niger seed, medicinal herbs, and safflower merchandise. Further, it offers value-added tailor made products to shape the components of cocoa butter equivalents. Its merchandise are main used in chocolate and confectionery, bakery, dairy, special vitamins, food service, personal care, and other industries. Manorama Industries Ltd incorporated in 2005 and is based in Raipur, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 71 | 69 | 78 | 73 | 81 | 95 | 102 | 112 | 118 | 98 |
Other Income | 3 | 3 | 2 | 1 | 1 | 1 | 3 | 3 | 2 | 4 |
Total Income | 74 | 72 | 79 | 74 | 82 | 97 | 105 | 115 | 120 | 103 |
Total Expenditure | 62 | 60 | 66 | 60 | 69 | 80 | 85 | 93 | 99 | 83 |
Operating Profit | 12 | 12 | 13 | 13 | 13 | 16 | 20 | 22 | 21 | 20 |
Interest | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 5 | 6 |
Depreciation | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 8 | 8 | 9 | 10 | 8 | 11 | 14 | 16 | 12 | 11 |
Provision for Tax | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 3 |
Profit After Tax | 6 | 6 | 7 | 7 | 6 | 7 | 10 | 12 | 9 | 7 |
Adjustments | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 6 | 6 | 7 | 7 | 6 | 7 | 10 | 12 | 9 | 7 |
Adjusted Earnings Per Share | 1.1 | 1 | 1.1 | 1.1 | 1 | 1.2 | 1.7 | 1.9 | 1.4 | 1.2 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 104 | 133 | 131 | 145 | 219 | 102 | 188 | 203 | 279 | 351 | 430 |
Other Income | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 6 | 8 | 6 | 12 |
Total Income | 105 | 133 | 132 | 146 | 222 | 106 | 194 | 209 | 287 | 357 | 443 |
Total Expenditure | 101 | 129 | 127 | 143 | 204 | 74 | 144 | 168 | 240 | 294 | 360 |
Operating Profit | 5 | 4 | 4 | 4 | 18 | 32 | 50 | 41 | 47 | 63 | 83 |
Interest | 3 | 2 | 2 | 1 | 2 | 5 | 10 | 10 | 6 | 9 | 15 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 8 | 8 | 8 | 11 | 13 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 2 | 2 | 16 | 27 | 32 | 22 | 34 | 43 | 53 |
Provision for Tax | 0 | 0 | 1 | 1 | 6 | 7 | 9 | 8 | 9 | 13 | 16 |
Profit After Tax | 1 | 1 | 1 | 1 | 10 | 19 | 23 | 15 | 24 | 30 | 38 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 1 | 1 | 1 | 10 | 19 | 23 | 15 | 24 | 30 | 38 |
Adjusted Earnings Per Share | 0.3 | 0.3 | 0.3 | 0.4 | 2.6 | 3.4 | 4.2 | 2.6 | 4.1 | 5 | 6.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 26% | 23% | 10% | 0% |
Operating Profit CAGR | 34% | 8% | 28% | 0% |
PAT CAGR | 25% | 9% | 25% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 145% | 46% | 70% | NA% |
ROE Average | 11% | 11% | 17% | 17% |
ROCE Average | 13% | 13% | 20% | 24% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 9 | 10 | 13 | 14 | 24 | 104 | 127 | 145 | 268 | 298 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 15 | 30 | 24 |
Other Non-Current Liabilities | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 3 | 3 | 6 |
Total Current Liabilities | 12 | 7 | 7 | 8 | 21 | 29 | 161 | 91 | 95 | 96 |
Total Liabilities | 21 | 16 | 20 | 22 | 46 | 133 | 289 | 254 | 396 | 424 |
Fixed Assets | 2 | 3 | 3 | 3 | 3 | 6 | 51 | 57 | 55 | 97 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 1 | 29 | 12 | 17 | 61 | 57 |
Total Current Assets | 19 | 14 | 17 | 20 | 42 | 98 | 226 | 180 | 280 | 270 |
Total Assets | 21 | 16 | 20 | 22 | 46 | 133 | 289 | 254 | 396 | 424 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 6 | 7 | 7 | 10 | 16 | 0 | 2 | 1 | 0 | 49 |
Cash Flow from Operating Activities | 0 | 10 | 1 | 11 | -11 | -11 | -60 | 33 | -33 | 59 |
Cash Flow from Investing Activities | 1 | -0 | -0 | 0 | -1 | -50 | -10 | 11 | -35 | -99 |
Cash Flow from Financing Activities | -0 | -10 | 2 | -5 | 16 | 63 | 85 | -45 | 117 | -7 |
Net Cash Inflow / Outflow | 0 | 0 | 3 | 6 | 3 | 2 | 15 | -0 | 49 | -47 |
Closing Cash & Cash Equivalent | 7 | 7 | 10 | 16 | 19 | 2 | 17 | 0 | 49 | 2 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.29 | 0.31 | 0.29 | 0.36 | 2.63 | 3.43 | 4.19 | 2.62 | 4.05 | 5 |
CEPS(Rs) | 0.49 | 0.53 | 0.51 | 0.58 | 2.82 | 3.57 | 5.57 | 4.05 | 5.38 | 6.82 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 |
Book NAV/Share(Rs) | 2.83 | 3.13 | 3.44 | 3.81 | 6.44 | 18.68 | 22.87 | 26.01 | 45.01 | 50.01 |
Core EBITDA Margin(%) | 3.52 | 2.57 | 2.79 | 1.9 | 7.17 | 27.62 | 23.29 | 17.11 | 13.95 | 16.09 |
EBIT Margin(%) | 3.84 | 2.74 | 2.64 | 1.96 | 8.06 | 30.38 | 22.38 | 16.21 | 14.08 | 14.74 |
Pre Tax Margin(%) | 1.19 | 1.09 | 1.28 | 1.41 | 7.26 | 25.94 | 17.19 | 11.04 | 12.01 | 12.27 |
PAT Margin (%) | 0.86 | 0.71 | 0.83 | 0.95 | 4.53 | 18.61 | 12.4 | 7.2 | 8.65 | 8.49 |
Cash Profit Margin (%) | 1.44 | 1.23 | 1.48 | 1.51 | 4.85 | 19.41 | 16.47 | 11.12 | 11.48 | 11.58 |
ROA(%) | 4.25 | 5.03 | 5.97 | 6.54 | 29.07 | 21.29 | 11.07 | 5.37 | 7.43 | 7.26 |
ROE(%) | 10.37 | 10.3 | 9.56 | 10.05 | 51.36 | 29.73 | 20.19 | 10.72 | 11.69 | 10.52 |
ROCE(%) | 19.79 | 21.43 | 21.89 | 17.57 | 62.3 | 36.46 | 22.47 | 13.78 | 12.95 | 13.18 |
Receivable days | 11.06 | 5.74 | 1.92 | 1.81 | 2.26 | 28.16 | 29.49 | 34.78 | 31.02 | 27.4 |
Inventory Days | 26.62 | 14.43 | 11.67 | 9.3 | 16.59 | 98.08 | 181.35 | 246.15 | 198.97 | 176.23 |
Payable days | 1.84 | 2.96 | 4.79 | 12.74 | 8.47 | 10.36 | 75.68 | 63.3 | 18.94 | 10.53 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 11.53 | 14.54 | 61.73 | 57.43 | 41.23 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 2.11 | 2.67 | 6.22 | 5.17 | 4.12 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 |
EV/Net Sales(x) | 0.06 | -0.01 | -0.02 | -0.09 | 0.03 | 1.97 | 2.24 | 4.78 | 5.17 | 3.64 |
EV/Core EBITDA(x) | 1.47 | -0.28 | -0.72 | -3.67 | 0.35 | 6.32 | 8.48 | 23.73 | 30.56 | 20.42 |
Net Sales Growth(%) | 0 | 26.95 | -1.13 | 11.02 | 50.78 | -53.32 | 83.83 | 7.64 | 37.75 | 25.68 |
EBIT Growth(%) | 0 | -9.42 | -4.95 | -17.59 | 521.12 | 76.04 | 35.43 | -22.03 | 19.59 | 31.64 |
PAT Growth(%) | 0 | 5.07 | 14.92 | 27.08 | 622.26 | 91.91 | 22.43 | -37.51 | 65.57 | 23.32 |
EPS Growth(%) | 0 | 4.39 | -6.3 | 27.08 | 622.27 | 30.2 | 22.43 | -37.51 | 54.57 | 23.32 |
Debt/Equity(x) | 1.34 | 0.41 | 0.38 | 0.01 | 0.74 | 0.24 | 0.94 | 0.59 | 0.4 | 0.37 |
Current Ratio(x) | 1.51 | 2.05 | 2.41 | 2.41 | 1.94 | 3.39 | 1.41 | 1.97 | 2.95 | 2.82 |
Quick Ratio(x) | 0.89 | 1.62 | 1.63 | 2.18 | 1.1 | 2.11 | 0.47 | 0.62 | 1.04 | 1.17 |
Interest Cover(x) | 1.45 | 1.66 | 1.94 | 3.56 | 10.11 | 6.84 | 4.31 | 3.13 | 6.8 | 5.97 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0.11 | 0.35 | 0.09 | 0.08 | 0.09 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 | 57.26 |
FII | 2.4 | 2.4 | 2.4 | 2.44 | 2.2 | 2.27 | 2.59 | 2.79 | 2.81 | 2.53 |
DII | 3.4 | 3.4 | 3.4 | 3.46 | 3.46 | 3.46 | 3.4 | 3.26 | 2.55 | 2.51 |
Public | 36.94 | 36.94 | 36.94 | 36.85 | 37.09 | 37.02 | 36.75 | 36.69 | 37.39 | 37.71 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 3.41 |
FII | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.15 |
DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.15 |
Public | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.45 | 2.25 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 5.96 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About